Entrada Therapeutics, Inc. (TRDA) shares outstanding

Shares outstanding · fiscal 2025
41.37M

Entrada Therapeutics, Inc. (TRDA) had 41.37M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.1% higher than the 39.00M of fiscal 2024. Figures as of 18 Nov 2026, 12:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
41.37M
Change on fiscal 2024
+6.1%
Highest on record
41.37Mfiscal 2025
Lowest on record
31.29Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Entrada Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 39.15M shares outstanding today.

Across the 4 fiscal years on record (2022–2025), the highest was 41.37M in fiscal 2025 and the lowest 31.29M in fiscal 2022.

History · 4 fiscal years

Shares outstanding by fiscal year

Entrada Therapeutics, Inc. shares outstanding, year by year

Entrada Therapeutics, Inc. (TRDA) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202541.37M 6.1% up
202439.00M 18.0% up
202333.05M 5.6% up
202231.29M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on TRDA

Entrada Therapeutics, Inc., figure by figure

Entrada Therapeutics, Inc. (TRDA) overview: price, valuation and scorecard

Entrada Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Entrada Therapeutics, Inc. have?

Entrada Therapeutics, Inc. (TRDA) had 41.37M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 6.1% higher than the 39.00M of fiscal 2024. The market data feed counts 39.15M shares outstanding today.

What are the highest and lowest diluted share count figures on record for Entrada Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was 41.37M in fiscal 2025 and the lowest 31.29M in fiscal 2022.

How is Entrada Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Entrada Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Entrada Therapeutics, Inc. (TRDA) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/TRDA/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.